| Primary |
| Product Used For Unknown Indication |
45.5% |
| Drug Use For Unknown Indication |
13.6% |
| Depression |
5.2% |
| Hypertension |
4.5% |
| Intentional Overdose |
4.2% |
| Agitation |
3.1% |
| Drug Abuse |
3.1% |
| Psychotic Disorder |
2.4% |
| Bronchopulmonary Disease |
2.1% |
| Wrong Drug Administered |
2.1% |
| Hypothyroidism |
1.7% |
| Sedation |
1.7% |
| Anxiety |
1.4% |
| Dementia Alzheimer's Type |
1.4% |
| Ill-defined Disorder |
1.4% |
| Psychomotor Hyperactivity |
1.4% |
| Schizophrenia, Paranoid Type |
1.4% |
| Suicide Attempt |
1.4% |
| Bipolar Disorder |
1.0% |
| Diabetes Mellitus |
1.0% |
|
| Sopor |
28.1% |
| Suicide Attempt |
10.5% |
| Speech Disorder |
8.8% |
| Toxicity To Various Agents |
7.0% |
| Parkinsonism |
5.3% |
| Neutropenia |
3.5% |
| Palpitations |
3.5% |
| Rhabdomyolysis |
3.5% |
| Substance Abuse |
3.5% |
| Thrombocytopenia |
3.5% |
| Transient Ischaemic Attack |
3.5% |
| Tremor |
3.5% |
| Wrong Drug Administered |
3.5% |
| Balance Disorder |
1.8% |
| Bradycardia |
1.8% |
| Cognitive Disorder |
1.8% |
| Delirium |
1.8% |
| Drug Abuse |
1.8% |
| Drug Toxicity |
1.8% |
| Dyspnoea |
1.8% |
|
| Secondary |
| Product Used For Unknown Indication |
34.8% |
| Intentional Overdose |
17.9% |
| Depression |
10.0% |
| Drug Use For Unknown Indication |
7.9% |
| Panic Disorder |
5.7% |
| Hypertension |
4.7% |
| Epilepsy |
2.2% |
| Hallucination |
2.2% |
| Anxiety |
1.8% |
| Drug Administration Error |
1.8% |
| Dementia Alzheimer's Type |
1.4% |
| Suicide Attempt |
1.4% |
| Abnormal Behaviour |
1.1% |
| Hypothyroidism |
1.1% |
| Major Depression |
1.1% |
| Psychotic Disorder |
1.1% |
| Sedative Therapy |
1.1% |
| Sleep Disorder |
1.1% |
| Type 2 Diabetes Mellitus |
1.1% |
| Agitation |
0.7% |
|
| Toxicity To Various Agents |
18.0% |
| Sopor |
16.4% |
| Rhabdomyolysis |
6.6% |
| Paresis |
4.9% |
| Parkinsonism |
4.9% |
| Sluggishness |
4.9% |
| Speech Disorder |
4.9% |
| Suicide Attempt |
4.9% |
| Transient Ischaemic Attack |
4.9% |
| Drowning |
3.3% |
| Electrolyte Imbalance |
3.3% |
| Hyponatraemic Syndrome |
3.3% |
| Somnolence |
3.3% |
| Tremor |
3.3% |
| Vertigo |
3.3% |
| Wrong Drug Administered |
3.3% |
| Delirium |
1.6% |
| Drug Abuse |
1.6% |
| Extrapyramidal Disorder |
1.6% |
| Facial Palsy |
1.6% |
|
| Concomitant |
| Drug Use For Unknown Indication |
15.9% |
| Product Used For Unknown Indication |
13.7% |
| Sepsis |
8.8% |
| Pain |
5.3% |
| Hypertension |
4.9% |
| Epilepsy |
4.4% |
| Depression |
4.0% |
| Diuretic Therapy |
4.0% |
| Nuclear Magnetic Resonance Imaging |
4.0% |
| Aggression |
3.5% |
| Agitation |
3.5% |
| Hypokalaemia |
3.5% |
| Insomnia |
3.5% |
| Scan With Contrast |
3.5% |
| Chronic Obstructive Pulmonary Disease |
3.1% |
| Constipation |
3.1% |
| Nausea |
3.1% |
| Psychotic Disorder |
3.1% |
| Acute Coronary Syndrome |
2.7% |
| Abnormal Behaviour |
2.2% |
|
| Ulcer |
10.2% |
| Blood Alkaline Phosphatase Increased |
8.2% |
| Hyponatraemia |
8.2% |
| International Normalised Ratio Increased |
8.2% |
| Renal Failure |
6.1% |
| Urinary Incontinence |
6.1% |
| Vomiting |
6.1% |
| Acute Pulmonary Oedema |
4.1% |
| Hyperventilation |
4.1% |
| Melaena |
4.1% |
| Nephrogenic Systemic Fibrosis |
4.1% |
| Red Blood Cell Count Decreased |
4.1% |
| Sopor |
4.1% |
| Sudden Death |
4.1% |
| Thrombocytopenia |
4.1% |
| Toothache |
4.1% |
| Upper Limb Fracture |
4.1% |
| Death |
2.0% |
| Disseminated Intravascular Coagulation |
2.0% |
| Drug Ineffective |
2.0% |
|
| Interacting |
| Drug Use For Unknown Indication |
100.0% |
|
| Neuroleptic Malignant Syndrome |
100.0% |
|
